HMP Global’s drug forum taps pricing expert Ciaccia as 2027 change accelerates

written by Samuel Reed · 3 days ago
HMP Global’s drug forum taps pricing expert Ciaccia as 2027 change accelerates

The pharmaceutical supply chain is under immense pressure from shifting federal policies, affordability crises, and new competitive dynamics—and the leaders who navigate these changes will shape the industry for years. That is the urgent backdrop for the return of HMP Global’s Drug Channels Leadership Forum (DCLF), an invitation-only gathering now in its third year, set for March 15-17, 2027, in Miami, Florida. Drug Channels Institute (DCI), an HMP Global company, has announced that nationally recognized drug pricing expert Antonio Ciaccia will join as moderator.

Industry executives face a landscape defined by mounting affordability pressures, evolving federal policies, and shifting competitive dynamics across the entire supply chain. The choices made today, organizers emphasize, will carry lasting consequences for business models, market access, and patient care.

The 2027 program is built around three core elements. First, candid conversations will tackle the defining issues of the drug channel’s future, including drug affordability, the future of community pharmacy, federal policy, Medicare sustainability, and the evolving relationships among manufacturers, pharmacy benefit managers (PBMs), payers, and pharmacies. Second, leading experts will provide perspective: Antonio Ciaccia of 3 Axis Advisors and Eric Percher of Nephron Research will offer insights into financial, regulatory, and competitive forces, alongside industry executives participating in keynotes, fireside chats, and interactive discussions. Third, focused sessions will address critical market developments, with talks titled “Wall Street’s View of the Drug Channel,” “All Roads Lead to GLP-1s,” and “340B at an Inflection Point: What Comes Next for the Drug Channel.”

Also worth a look: Niigata, home to thousands of swans, hosts global wetland mayors summit and Durango designer swaps red and green for woodland gold at Festival of Trees.

Nationally Recognized Drug Pricing Expert Antonio Ciaccia Joins DCLF as Moderator

For the 2027 edition, Ciaccia—president of 3 Axis Advisors and CEO and co-founder of 46brooklyn Research—will guide conversations across the program. His two organizations concentrate on prescription drug pricing and the economics of the U.S. drug supply chain. Ciaccia has a well-established record of making drug channel economics more transparent, spanning Medicaid audits, pharmacy policy, and commercial benefits consulting. His data analytics work has helped government officials uncover and recover over a billion dollars in states across the country, a track record directly relevant to DCLF’s focus on affordability, financial incentives, and who ultimately pays. He has presented and testified before state legislative oversight bodies, Congress, national employer groups, and most recently at the United State Department of Labor on drug pricing realities, tying policy to its consequences for reimbursement, pharmacy access, and channel strategy.

“For years, we have wondered when change was going to happen across the prescription drug supply chain. Change is here, and it’s occurring at a remarkable pace,” Ciaccia said. “DCLF puts you in the room with the people leading that change in real time. These are the people who matter, talking about the issues that matter, in a raw, unfiltered environment.”

A key distinction of this forum is its closed-door nature: unlike traditional industry conferences, DCLF is closed to media and press. Organizers say this creates a trusted environment where senior leaders can speak candidly, challenge conventional thinking, and debate the forces shaping the drug channel without concern for public record.

“DCI helps leaders understand how the drug channel works and what its evolution means for their businesses,” said Tyler Novotny, SVP, Drug Channels Institute. “DCLF brings that mission into the room. With no press or recordings, senior leaders can speak candidly, challenge assumptions, and better understand the perspectives shaping decisions across the industry.”

Requests for invitation to DCLF 2027 are open now. To be considered, visit the DCLF website.

Why it matters: As drug pricing reform accelerates and supply chain relationships grow more adversarial, forums like DCLF offer a rare space for unfiltered debate among the very executives whose decisions will determine market access and patient affordability. The inclusion of an independent pricing expert like Ciaccia signals that transparency—not just industry talking points—will be central to those conversations.

ABOUT DRUG CHANNELS INSTITUTE
Drug Channels Institute (DCI), an HMP Global company, provides industry-leading analysis and insights on the complex U.S. pharmaceutical distribution and reimbursement system. Through research, commentary, executive forums, and industry engagement, DCI helps leaders understand the market forces, business models, and policy developments shaping the prescription drug supply chain. It is also home to the Drug Channels Leadership Forum, an invitation-only gathering of C-suite executives and senior decisionmakers from across the pharmaceutical ecosystem.

ABOUT HMP GLOBAL
HMP Global is the trusted leader in healthcare events, education and omnichannel engagement, with a mission to improve patient care by bringing the healthcare community together. For more than 40 years, the company has built trusted brands that healthcare professionals rely on throughout their careers, including Psych Congress, the nation’s leading conference on practical psychopharmacology; the Symposium on Advanced Wound Care (SAWC), the world’s largest wound care meeting; EMS World Expo; NEI; LINC; and Advances in IBD. Today, HMP Global’s portfolio includes 27 brands and 83 events that connect more than 2 million healthcare professionals with more than 6,000 leading experts through live experiences, accredited education, year-round engagement through HMP Collective, and first-party clinician intelligence powered by Viia, creating one of the largest healthcare engagement ecosystems. Learn more at hmpglobal.com or follow the company on LinkedIn.

Brittany Pride Sellitto
HMP Global
Bsellitto@hmpglobal.com


Samuel Reed

Samuel Reed

Samuel Reed is a senior journalist covering the intersection of business, technology, and society. With over a decade of experience, his work focuses on artificial intelligence, corporate governance, and emerging tech trends.

You May Also Like